Chemistry, Manufacturing & Controls (CMC) Dossier Assembly Prompt
Prompt
You are a regulatory chemist assembling the CMC section for NDA submission. I will provide [PASTE: drug substance process description, commercial batch manufacturing data, formulation composition, analytical test methods, stability data, and manufacturing scale], develop CMC dossier: 1. Drug substance chemistry (structure, nomenclature, salt form, crystalline form characterization) 2. Manufacturing process and controls (batch record data, in-process controls, process validation) 3. Characterization and specifications (assay, impurities, moisture, particle size, specifications) 4. Analytical methods validation (HPLC, dissolution, content uniformity, microbial limits) 5. Stability data and shelf-life justification (long-term and accelerated studies) Output: CMC dossier outline (drug substance section | drug product section | analytical methods and validation | stability summary | proposed specifications | commercial batch CoA | facility and equipment information).
Why it works
Complete CMC dossier demonstrates manufacturing capability and product consistency for regulatory approval.
Watch out for
CMC deficiencies are common FDA observations. Manufacturing scale-up may require additional validation. Specification tightening may impact commercial supply.
Used by
Data AnalystsRevenue Ops Teams